News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 189
- Sources here
- 12
- Companies here
- 16
Search results
Stored financial headlines
Active search
189 matching headlines
Ticker or company: ANGHMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
How Anghami Became the Arab World’s Streaming Leader
Anghami, meaning "my tunes" in Arabic, emerged as the first legal music streaming platform and digital distribution company in the Arab world, founded by Eddy Maroun and Elie Habib in 2012. It quickly gained immense popularity by offering a vast catalog of licensed music …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Shanghai Henlius Biotech, Inc. Announces Approval of Investigational New Drug Application for Clinical Trial of HLX43 for Injection in Combination with Bevacizumab for Treatment of Advanced or Metastatic Solid Tumours
2696
main company
Sharemaestro market context
Price above Trend Line
52 weeks -19.4%
Price to book forward of Anghami Inc. – NASDAQ:ANGH
This article provides the "Price to book forward" for Anghami Inc. (NASDAQ: ANGH) on TradingView. It indicates that the market was closed and no trades were made at the time of the report. The content lists various financial data providers and highlights the extensive …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Enterprise value to EBITDA forward of Anghami Inc. – NASDAQ:ANGH
This article displays a financial metric, "Enterprise value to EBITDA forward," for Anghami Inc. (NASDAQ: ANGH). The content appears to be a stub or a placeholder page from TradingView, indicating that the specific financial data for this metric might not have been loaded yet …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Industrial And Commercial Bank Of China (SEHK:1398) Tests Repo Based Loans, Is The Stock Still Cheap?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Industrial and Commercial Bank of China (SEHK:1398) has drawn attention after joining China Merchants Bank and Shanghai Pudong Development Bank in testing loans …
600000
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.0% · Next-week setup negative 41.6%
Anghami Inc (ANGH) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Anghami Inc (ANGH), focusing on support, resistance, indicators, and moving averages. It details various technical indicators like MACD, RSI, and CCI, along with their values and directional signals. The analysis also covers moving averages from MA5 to …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Anghami Inc (ANGH) Income Statement
This article provides an income statement for Anghami Inc (ANGH), offering details on its quarterly and annual financial performance. It includes key financial metrics like revenue and net income for fiscal year 2025, along with an FAQ section explaining how to interpret an income …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Anghami Inc (ANGH) Cash Flow
This article provides an overview of Anghami Inc's (ANGH) cash flow statements, including operating, investing, and financing cash flows, along with free cash flow. It details key financial figures such as Anghami generating -36.25M in operating cash flow in fiscal 2025 and -37.04M in …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Anghami Inc (ANGH) Institutional Confidence
This article provides an overview of Anghami Inc.'s (ANGH) institutional confidence, detailing major shareholders and changes in their holdings. Key institutional investors include Warner Bros. Discovery, Inc. and Kuwait Projects Company Holding KSCP, with significant adjustments in their share percentages. The data also highlights …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Anghami Inc (ANGH) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Anghami Inc (ANGH), identifying its major shareholders and their respective proportions, including corporations, holding companies, and individual investors. It also provides a historical overview of institutional shareholdings, showing changes in the number of institutions and shares held …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Anghami Inc|Price:3.390|Chg%:+0.170
This article provides an overview of Anghami Inc (ANGH) stock performance, showing a trading price of $3.390, up 5.31%. It details the methodology TradingKey uses to generate its comprehensive stock scores for companies like Anghami Inc, covering financial health, valuation, earnings forecasts, price momentum, …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Anghami Inc (ANGH) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Anghami Inc (ANGH), detailing its volatility, financial risk, and investment risk metrics. It includes data points such as Beta vs S&P 500 index, maximum drawdown, daily returns, Sharpe Ratio, and various volatility measures over different periods. The …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC
Junshi Biosciences SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental application for toripalimab in combination …
688180
main company
Sharemaestro market context
Trend signal started
52 weeks -5.0% · Next-week setup negative 44.4%
Anghami Inc (ANGH) director Fine N Scott submits initial Form 3 insider report
Anghami Inc. director Fine N Scott has filed an initial Form 3, which is an opening statement of beneficial ownership, indicating that Scott is now a reporting insider for the company. This filing confirms Scott's role as a director but does not report any …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%